ナチュラルキラー（NK）細胞療法の世界市場レポート (2025年)

ナチュラルキラー（NK）細胞療法の市場規模は、今後数年で急成長が見込まれます。2029年には年間平均成長率（CAGR）12.3％で63億米ドルに成長します。予測期間中の成長は、臨床試験の増加、免疫療法の研究開発投資の増加、固形がんへの応用拡大、戦略的提携、細胞療法に対する規制当局の支援、個別化がん治療に対する需要の高まりなどの要因によってもたらされます。予測期間における主な動向としては、遺伝子工学の革新、CAR-NK療法の進展、細胞拡大技術の改善、臨床試験活動の革新、既製NK細胞製品の開発、固形がん治療の進展などが挙げられます。

がんの有病率の増加は、今後数年間におけるナチュラルキラー（NK）細胞療法市場の成長を牽引すると予想されます。がんは、制御不能な異常細胞の増殖を伴い、それが近隣の組織に侵入して身体の他の部位に広がり、正常な細胞調節を乱し、腫瘍を形成し、身体機能を損ないます。汚染物質、タバコの煙、化学物質への暴露などの環境因子は、DNAを傷つけ、細胞機能を乱し、がんのリスクを高めます。NK細胞治療薬は、事前の感作を必要とせず、腫瘍細胞を直接標的とし、排除することでがんを治療します。例えば、米国を拠点とする非営利団体である米国がん協会は2024年4月、2022年に世界で新たに2,000万人ががんと診断され、970万人ががんで死亡したと報告しました。2050年には、主に人口増加によって、がん患者数は3,500万人に増加すると予測されています。その結果、がん有病率の増加がNK細胞治療薬市場の拡大に拍車をかけています。

主要企業は、費用対効果の高い既製のNK細胞療法を可能にするため、スケーラブルなiPSCベースのNK細胞製造プラットフォームの開発などの進歩に注力しています。これらのプラットフォームは、人工多能性幹細胞（iPSC）を用いて、標準化されたフィーダー不要の閉鎖系バイオリアクター環境でNK細胞を作製し、高い収率と規制遵守を保証します。例えば、2025年4月、ベルギーを拠点とするバイオテクノロジー企業Cellistic社は、NK細胞療法のためのiPSCベースの製造ソリューションであるEcho-NKプラットフォームを発表しました。このプラットフォームは、血液がん、固形がん、自己免疫疾患をターゲットとするNK細胞のスケーラブルな生産を可能にし、すべての主要な拡大工程は、Cellistic社のEMA認定GMP施設内のバイオリアクター閉鎖系で行われます。セリスティックのパルス細胞株開発能力と独自のSTAR-CRISPR技術を取り入れることで、Echo-NKプラットフォームは、特定の遺伝子編集を施した安定したiPSC細胞株の開発を加速し、既製のNK細胞療法のための商業的に実行可能なソリューションを提供します。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場のマクロ経済シナリオ：金利・インフレ・地政学・貿易戦争・関税・コロナ禍と回復が市場に及ぼす影響を含む

第5章 世界の成長分析と戦略分析フレームワーク

• 世界のナチュラルキラー（NK）細胞療法市場：PESTEL分析（政治・社会・技術・環境・法的要因、促進要因、抑制要因）
• 最終用途産業の分析
• 世界のナチュラルキラー（NK）細胞療法市場：成長率分析
• 世界のナチュラルキラー（NK）細胞療法の市場規模・成長率：実績値、2019～2024年
• 世界のナチュラルキラー（NK）細胞療法の市場規模・成長率：予測値、2024～2029年、2034年
• 世界のナチュラルキラー（NK）細胞療法市場：総有効市場（TAM）

第6章 市場セグメンテーション

• 世界のナチュラルキラー（NK）細胞療法市場：治療法別、実績値・予測値、2019～2024年、2024～2029年、2034年
• NK細胞標的抗体
• NK細胞療法
• 世界のナチュラルキラー（NK）細胞療法市場：用途別、実績値・予測値、2019～2024年、2024～2029年、2034年
• 免疫増殖性疾患
• 消化器疾患
• がん
• その他の用途
• 世界のナチュラルキラー（NK）細胞療法市場：流通チャネル別、実績値・予測値、2019～2024年、2024～2029年、2034年
• 病院薬局
• 直接入札
• その他の流通チャネル
• 世界のナチュラルキラー（NK）細胞療法市場：エンドユーザー別、実績値・予測値、2019～2024年、2024～2029年、2034年
• 研究・学術機関
• 病院
• 専門クリニック
• 世界のナチュラルキラー（NK）細胞療法市場：NK細胞標的抗体の種類別、実績値・予測値、2019～2024年、2024～2029年、2034年
• モノクローナル抗体（mAb）
• 二重特異性抗体（BsAb）
• 抗体薬物複合体（ADC）
• 世界のナチュラルキラー（NK）細胞療法市場：NK細胞療法の種類別、実績値・予測値、2019～2024年、2024～2029年、2034年
• 自家NK細胞療法
• 同種NK細胞療法
• CAR（キメラ抗原受容体）-NK細胞療法

第7章 地域別・国別の分析

• 世界のナチュラルキラー（NK）細胞療法市場：地域別、実績値・予測値、2019～2024年、2024～2029年、2034年
• 世界のナチュラルキラー（NK）細胞療法市場：国別、実績値・予測値、2019～2024年、2024～2029年、2034年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• ナチュラルキラー（NK）細胞療法市場：競合情勢
• ナチュラルキラー（NK）細胞療法市場：企業プロファイル
  • Sanofi S.A.（概要、製品・サービス、戦略、財務分析）
  • Thermo Fisher Scientific（概要、製品・サービス、戦略、財務分析）
  • Lonza AG（概要、製品・サービス、戦略、財務分析）
  • Catalent（概要、製品・サービス、戦略、財務分析）
  • Kite Pharma（概要、製品・サービス、戦略、財務分析）

第31章 その他の大手企業と革新的企業

• Fate Therapeutics
• Artiva Biotherapeutics
• Nkarta, Inc
• Celularity Inc.
• NKGen Biotech
• Dragonfly Therapeutics
• Cytovia Therapeutics
• Glycostem Therapeutics
• Gamida Cell
• ONK Therapeutics
• Wugen Inc.
• AGC Biologics
• CytoImmune Therapeutics
• XNK Therapeutics
• Indapta Therapeutics

第32章 世界市場：競合ベンチマーキング・ダッシュボード

第33章 主要な企業合併・買収 (M&A)

第34章 最近の市場動向

第35章 市場の潜在力の高い国・部門と戦略

• ナチュラルキラー（NK）細胞療法市場：最新機会を提供する国（2029年）
• ナチュラルキラー（NK）細胞療法市場：最新機会を提供する部門（2029年）
• ナチュラルキラー（NK）細胞療法市場：成長戦略（2029年）
  • 市場動向に基づく戦略
  • 競争戦略

第36章 付録

Natural killer (NK) cell therapeutics are treatments that utilize or boost NK cells, a type of immune cell, to identify and eliminate cancer cells, infected cells, or other abnormal cells. These therapies encompass NK cell infusions (autologous/allogeneic), CAR-NK cells (genetically engineered to target specific proteins), and NK-targeting antibodies (bispecific antibodies).

The primary forms of NK cell therapeutics are NK cell-targeting antibodies and NK cell-based treatments. NK cell-targeting antibodies are designed to enhance NK cells' capacity to detect and destroy cancer cells by binding to tumor-specific antigens. These therapies are used in areas such as cancer, immunoproliferative disorders, gastrointestinal conditions, and more. Distribution methods include hospital pharmacies, direct tenders, and additional channels, while the main end-users are hospitals, specialty clinics, and research and academic institutions.

The natural killer (nk) cell therapeutics market research report is one of a series of new reports from The Business Research Company that provides natural killer (nk) cell therapeutics market statistics, including the natural killer (nk) cell therapeutics industry global market size, regional shares, competitors with the natural killer (nk) cell therapeutics market share, detailed natural killer (nk) cell therapeutics market segments, market trends, and opportunities, and any further data you may need to thrive in the natural killer (nk) cell therapeutics industry. This natural killer (nk) cell therapeutics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The natural killer (NK) cell therapeutics market size has grown rapidly in recent years. It will grow from $3.52 billion in 2024 to $3.96 billion in 2025 at a compound annual growth rate (CAGR) of 12.6%. The growth during the historical period can be attributed to factors such as the rise in cancer incidence, increased R&D funding, greater awareness of immunotherapy, growth in strategic industry partnerships, enhanced regulatory support, and advancements in cell expansion technologies.

The natural killer (NK) cell therapeutics market size is expected to see rapid growth in the next few years. It will grow to $6.3 billion in 2029 at a compound annual growth rate (CAGR) of 12.3%. The projected growth during the forecast period is driven by factors including an increase in clinical trials, rising investment in immunotherapy R&D, expanding applications in solid tumors, strategic collaborations, regulatory support for cell therapies, and growing demand for personalized cancer treatments. Key trends in the forecast period involve innovations in genetic engineering, advancements in CAR-NK therapies, improvements in cell expansion techniques, innovation in clinical trial activities, the development of off-the-shelf NK cell products, and progress in treatments for solid tumors.

The increasing prevalence of cancer is expected to drive the growth of the natural killer (NK) cell therapeutics market in the coming years. Cancer involves the uncontrolled growth of abnormal cells that invade nearby tissues and spread to other parts of the body, disrupting normal cell regulation, forming tumors, and impairing bodily functions. Environmental factors, such as exposure to pollutants, tobacco smoke, and chemicals, can damage DNA and disturb cellular functions, increasing the risk of cancer. NK cell therapeutics treat cancer by directly targeting and eliminating tumor cells without the need for prior sensitization. For example, the American Cancer Society, a U.S.-based non-profit organization, reported in April 2024 that in 2022, 20 million new cancer cases were diagnosed, and 9.7 million people died from the disease worldwide. It is predicted that by 2050, the number of cancer cases will rise to 35 million, driven primarily by population growth. As a result, the growing prevalence of cancer is fueling the expansion of the NK cell therapeutics market.

Major companies are focusing on advancements such as developing scalable iPSC-based NK cell manufacturing platforms to enable cost-effective, off-the-shelf NK cell therapies. These platforms use induced pluripotent stem cells (iPSCs) to generate NK cells in a standardized, feeder-free, closed-system bioreactor environment, ensuring high yields and regulatory compliance. For instance, in April 2025, Belgium-based biotechnology company Cellistic launched the Echo-NK platform, an iPSC-based manufacturing solution for NK cell therapies. This platform enables scalable production of NK cells targeting blood cancers, solid tumors, and autoimmune diseases, with all key expansion steps conducted in bioreactor closed systems within Cellistic's EMA-certified GMP facility. By incorporating Cellistic's Pulse cell line development capabilities and proprietary STAR-CRISPR technology, the Echo-NK platform accelerates the development of stable iPSC cell lines with specific gene edits, offering a commercially viable solution for off-the-shelf NK cell therapies.

In March 2025, AstraZeneca, a British-Swedish multinational pharmaceutical and biotechnology company, acquired EsoBiotec for up to \$1 billion, which includes an initial payment of \$425 million and up to \$575 million in milestone-based contingent payments. AstraZeneca intends to utilize EsoBiotec's platform to make cell therapies more accessible, scalable, and affordable for cancer patients worldwide, marking a significant expansion in its cell therapy portfolio. EsoBiotec is a Belgian-based biotech company specializing in cell therapeutics development.

Major players in the natural killer (nk) cell therapeutics market are Sanofi S.A., Thermo Fisher Scientific, Lonza AG, Catalent, Kite Pharma, Fate Therapeutics, Artiva Biotherapeutics, Nkarta Inc, Celularity Inc., NKGen Biotech, Dragonfly Therapeutics, Cytovia Therapeutics, Glycostem Therapeutics, Gamida Cell, ONK Therapeutics, Wugen Inc., AGC Biologics, CytoImmune Therapeutics, XNK Therapeutics, Indapta Therapeutics, Neukio Biotherapeutics, Senti Biosciences, WuXi Advanced Therapies, and Kiadis Pharma.

North America was the largest region in the natural killer (NK) cell therapeutics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in natural killer (NK) cell therapeutics report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the natural killer (NK) cell therapeutics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The natural killer (NK) cell therapeutics market includes revenues earned by entities by providing services such as scell therapy development, clinical trial support, contract manufacturing, regulatory consulting, and cell line engineering. The market value includes the value of related goods sold by the service provider or included within the service offering. The natural killer (NK) cell therapeutics market also includes sales of cytokine-activated NK cells, CAR-NK cell therapies, cell expansion kits, reagents, and culture media. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Natural Killer (NK) Cell Therapeutics Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on natural killer (nk) cell therapeutics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for natural killer (nk) cell therapeutics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The natural killer (nk) cell therapeutics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Therapeutics: Natural Killer (NK) Cell Directed Antibodies; Natural Killer (NK) Cell Therapies
• 2) By Application: Immunoproliferative Disorders; Gastrointestinal Diseases; Cancer; Other Applications
• 3) By Distribution Channel: Hospital Pharmacies; Direct Tender; Other Distribution Channels
• 4) By End User: Research And Academic Institutes; Hospitals; Specialty Clinics
• Subsegments:
• 1) By Natural Killer (NK) Cell Directed Antibodies: Monoclonal Antibodies (mAbs), Bispecific Antibodies (BsAbs), Antibody-Drug Conjugates (ADCs)
• 2) By Natural Killer (NK) Cell Therapies: Autologous NK Cell Therapies, Allogeneic NK Cell Therapies, Chimeric Antigen Receptor (CAR)-NK Cell Therapies
• Companies Mentioned: Sanofi S.A.; Thermo Fisher Scientific; Lonza AG; Catalent; Kite Pharma
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Natural Killer (NK) Cell Therapeutics Market Characteristics

3. Natural Killer (NK) Cell Therapeutics Market Trends And Strategies

4. Natural Killer (NK) Cell Therapeutics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Natural Killer (NK) Cell Therapeutics Growth Analysis And Strategic Analysis Framework

• 5.1. Global Natural Killer (NK) Cell Therapeutics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Natural Killer (NK) Cell Therapeutics Market Growth Rate Analysis
• 5.4. Global Natural Killer (NK) Cell Therapeutics Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Natural Killer (NK) Cell Therapeutics Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Natural Killer (NK) Cell Therapeutics Total Addressable Market (TAM)

6. Natural Killer (NK) Cell Therapeutics Market Segmentation

• 6.1. Global Natural Killer (NK) Cell Therapeutics Market, Segmentation By Therapeutics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Natural Killer (NK) Cell Directed Antibodies
• Natural Killer (NK) Cell Therapies
• 6.2. Global Natural Killer (NK) Cell Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Immunoproliferative Disorders
• Gastrointestinal Diseases
• Cancer
• Other Applications
• 6.3. Global Natural Killer (NK) Cell Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospital Pharmacies
• Direct Tender
• Other Distribution Channels
• 6.4. Global Natural Killer (NK) Cell Therapeutics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Research And Academic Institutes
• Hospitals
• Specialty Clinics
• 6.5. Global Natural Killer (NK) Cell Therapeutics Market, Sub-Segmentation Of Natural Killer (NK) Cell Directed Antibodies, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Monoclonal Antibodies (mAbs)
• Bispecific Antibodies (BsAbs)
• Antibody-Drug Conjugates (ADCs)
• 6.6. Global Natural Killer (NK) Cell Therapeutics Market, Sub-Segmentation Of Natural Killer (NK) Cell Therapies, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Autologous NK Cell Therapies
• Allogeneic NK Cell Therapies
• Chimeric Antigen Receptor (CAR)-NK Cell Therapies

7. Natural Killer (NK) Cell Therapeutics Market Regional And Country Analysis

• 7.1. Global Natural Killer (NK) Cell Therapeutics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Natural Killer (NK) Cell Therapeutics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Natural Killer (NK) Cell Therapeutics Market

• 8.1. Asia-Pacific Natural Killer (NK) Cell Therapeutics Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Natural Killer (NK) Cell Therapeutics Market, Segmentation By Therapeutics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Natural Killer (NK) Cell Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Natural Killer (NK) Cell Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Natural Killer (NK) Cell Therapeutics Market

• 9.1. China Natural Killer (NK) Cell Therapeutics Market Overview
• 9.2. China Natural Killer (NK) Cell Therapeutics Market, Segmentation By Therapeutics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Natural Killer (NK) Cell Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Natural Killer (NK) Cell Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Natural Killer (NK) Cell Therapeutics Market

• 10.1. India Natural Killer (NK) Cell Therapeutics Market, Segmentation By Therapeutics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Natural Killer (NK) Cell Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Natural Killer (NK) Cell Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Natural Killer (NK) Cell Therapeutics Market

• 11.1. Japan Natural Killer (NK) Cell Therapeutics Market Overview
• 11.2. Japan Natural Killer (NK) Cell Therapeutics Market, Segmentation By Therapeutics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Natural Killer (NK) Cell Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Natural Killer (NK) Cell Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Natural Killer (NK) Cell Therapeutics Market

• 12.1. Australia Natural Killer (NK) Cell Therapeutics Market, Segmentation By Therapeutics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Natural Killer (NK) Cell Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Natural Killer (NK) Cell Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Natural Killer (NK) Cell Therapeutics Market

• 13.1. Indonesia Natural Killer (NK) Cell Therapeutics Market, Segmentation By Therapeutics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Natural Killer (NK) Cell Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Natural Killer (NK) Cell Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Natural Killer (NK) Cell Therapeutics Market

• 14.1. South Korea Natural Killer (NK) Cell Therapeutics Market Overview
• 14.2. South Korea Natural Killer (NK) Cell Therapeutics Market, Segmentation By Therapeutics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Natural Killer (NK) Cell Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Natural Killer (NK) Cell Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Natural Killer (NK) Cell Therapeutics Market

• 15.1. Western Europe Natural Killer (NK) Cell Therapeutics Market Overview
• 15.2. Western Europe Natural Killer (NK) Cell Therapeutics Market, Segmentation By Therapeutics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Natural Killer (NK) Cell Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Natural Killer (NK) Cell Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Natural Killer (NK) Cell Therapeutics Market

• 16.1. UK Natural Killer (NK) Cell Therapeutics Market, Segmentation By Therapeutics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Natural Killer (NK) Cell Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Natural Killer (NK) Cell Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Natural Killer (NK) Cell Therapeutics Market

• 17.1. Germany Natural Killer (NK) Cell Therapeutics Market, Segmentation By Therapeutics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Natural Killer (NK) Cell Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Natural Killer (NK) Cell Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Natural Killer (NK) Cell Therapeutics Market

• 18.1. France Natural Killer (NK) Cell Therapeutics Market, Segmentation By Therapeutics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Natural Killer (NK) Cell Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Natural Killer (NK) Cell Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Natural Killer (NK) Cell Therapeutics Market

• 19.1. Italy Natural Killer (NK) Cell Therapeutics Market, Segmentation By Therapeutics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Natural Killer (NK) Cell Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Natural Killer (NK) Cell Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Natural Killer (NK) Cell Therapeutics Market

• 20.1. Spain Natural Killer (NK) Cell Therapeutics Market, Segmentation By Therapeutics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Natural Killer (NK) Cell Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Natural Killer (NK) Cell Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Natural Killer (NK) Cell Therapeutics Market

• 21.1. Eastern Europe Natural Killer (NK) Cell Therapeutics Market Overview
• 21.2. Eastern Europe Natural Killer (NK) Cell Therapeutics Market, Segmentation By Therapeutics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Natural Killer (NK) Cell Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Natural Killer (NK) Cell Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Natural Killer (NK) Cell Therapeutics Market

• 22.1. Russia Natural Killer (NK) Cell Therapeutics Market, Segmentation By Therapeutics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Natural Killer (NK) Cell Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Natural Killer (NK) Cell Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Natural Killer (NK) Cell Therapeutics Market

• 23.1. North America Natural Killer (NK) Cell Therapeutics Market Overview
• 23.2. North America Natural Killer (NK) Cell Therapeutics Market, Segmentation By Therapeutics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Natural Killer (NK) Cell Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Natural Killer (NK) Cell Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Natural Killer (NK) Cell Therapeutics Market

• 24.1. USA Natural Killer (NK) Cell Therapeutics Market Overview
• 24.2. USA Natural Killer (NK) Cell Therapeutics Market, Segmentation By Therapeutics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Natural Killer (NK) Cell Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Natural Killer (NK) Cell Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Natural Killer (NK) Cell Therapeutics Market

• 25.1. Canada Natural Killer (NK) Cell Therapeutics Market Overview
• 25.2. Canada Natural Killer (NK) Cell Therapeutics Market, Segmentation By Therapeutics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Natural Killer (NK) Cell Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Natural Killer (NK) Cell Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Natural Killer (NK) Cell Therapeutics Market

• 26.1. South America Natural Killer (NK) Cell Therapeutics Market Overview
• 26.2. South America Natural Killer (NK) Cell Therapeutics Market, Segmentation By Therapeutics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Natural Killer (NK) Cell Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Natural Killer (NK) Cell Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Natural Killer (NK) Cell Therapeutics Market

• 27.1. Brazil Natural Killer (NK) Cell Therapeutics Market, Segmentation By Therapeutics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Natural Killer (NK) Cell Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Natural Killer (NK) Cell Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Natural Killer (NK) Cell Therapeutics Market

• 28.1. Middle East Natural Killer (NK) Cell Therapeutics Market Overview
• 28.2. Middle East Natural Killer (NK) Cell Therapeutics Market, Segmentation By Therapeutics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Natural Killer (NK) Cell Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Natural Killer (NK) Cell Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Natural Killer (NK) Cell Therapeutics Market

• 29.1. Africa Natural Killer (NK) Cell Therapeutics Market Overview
• 29.2. Africa Natural Killer (NK) Cell Therapeutics Market, Segmentation By Therapeutics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Natural Killer (NK) Cell Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Natural Killer (NK) Cell Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Natural Killer (NK) Cell Therapeutics Market Competitive Landscape And Company Profiles

• 30.1. Natural Killer (NK) Cell Therapeutics Market Competitive Landscape
• 30.2. Natural Killer (NK) Cell Therapeutics Market Company Profiles
  • 30.2.1. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Thermo Fisher Scientific Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Lonza AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Catalent Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Kite Pharma Overview, Products and Services, Strategy and Financial Analysis

31. Natural Killer (NK) Cell Therapeutics Market Other Major And Innovative Companies

• 31.1. Fate Therapeutics
• 31.2. Artiva Biotherapeutics
• 31.3. Nkarta, Inc
• 31.4. Celularity Inc.
• 31.5. NKGen Biotech
• 31.6. Dragonfly Therapeutics
• 31.7. Cytovia Therapeutics
• 31.8. Glycostem Therapeutics
• 31.9. Gamida Cell
• 31.10. ONK Therapeutics
• 31.11. Wugen Inc.
• 31.12. AGC Biologics
• 31.13. CytoImmune Therapeutics
• 31.14. XNK Therapeutics
• 31.15. Indapta Therapeutics

32. Global Natural Killer (NK) Cell Therapeutics Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Natural Killer (NK) Cell Therapeutics Market

34. Recent Developments In The Natural Killer (NK) Cell Therapeutics Market

35. Natural Killer (NK) Cell Therapeutics Market High Potential Countries, Segments and Strategies

• 35.1 Natural Killer (NK) Cell Therapeutics Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Natural Killer (NK) Cell Therapeutics Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Natural Killer (NK) Cell Therapeutics Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer